Tumours associated with BAP1 mutations

被引:195
作者
Murali, Rajmohan [1 ,2 ]
Wiesner, Thomas [2 ,3 ]
Scolyer, Richard A. [4 ,5 ,6 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA
[2] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA
[3] Med Univ Graz, Dept Dermatol, Graz, Austria
[4] Royal Prince Alfred Hosp, Sydney, NSW, Australia
[5] Univ Sydney, Sydney Med Sch, Discipline Pathol, Camperdown, NSW, Australia
[6] Melanoma Inst Australia, Sydney, NSW, Australia
关键词
3p21 loss syndrome; atypical Spitz tumour; BAP1; diagnosis; familial cancer; germline mutation; inherited tumour susceptibility; melanoma; pathology; skin; uveal melanoma; HISTONE DEACETYLASE INHIBITORS; POLYCOMB GROUP PROTEINS; RENAL-CELL CARCINOMA; DNA-DAMAGE RESPONSE; MALIGNANT MESOTHELIOMA; BREAST-CANCER; SPITZ NEVI; BRCA1-ASSOCIATED PROTEIN-1; MYELODYSPLASTIC SYNDROMES; PLEURAL MESOTHELIOMA;
D O I
10.1097/PAT.0b013e32835d0efb
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
BAP1 (BRCA1-Associated Protein 1) was initially identified as a protein that binds to BRCA1. BAP1 is a tumour suppressor that is believed to mediate its effects through chromatin modulation, transcriptional regulation, and possibly via the ubiquitin-proteasome system and the DNA damage response pathway. Germline mutations of BAP1 confer increased susceptibility for the development of several tumours, including uveal melanoma, epithelioid atypical Spitz tumours, cutaneous melanoma, and mesothelioma. However, the complete tumour spectrum associated with germline BAP1 mutations is not yet known. Somatic BAP1 mutations are seen in cutaneous melanocytic tumours (epithelioid atypical Spitz tumours and melanoma), uveal melanoma, mesothelioma, clear cell renal cell carcinoma, and other tumours. Here, we review the current state of knowledge about the functional roles of BAP1, and summarise data on tumours associated with BAP1 mutations. Awareness of these tumours will help pathologists and clinicians to identify patients with a high likelihood of harbouring germline or somatic BAP1 mutations. We recommend that pathologists consider testing for BAP1 mutations in epithelioid atypical Spitz tumours and uveal melanomas, or when other BAP1-associated tumours occur in individual patients. Tumour tissues may be screened for BAP1 mutations/loss/inactivation by immunohistochemistry (IHC) (demonstrated by loss of nuclear staining in tumour cells). Confirmatory sequencing may be considered in tumours that exhibit BAP1 loss by IHC and in those with equivocal IHC results. If a BAP1 mutation is confirmed in a tumour, the patient's treating physician should be informed of the possibility of a BAP1 germline mutation, so they can consider whether genetic counselling and further testing of the patient and investigation of their family is appropriate. Recognition and evaluation of larger numbers of BAP1-associated tumours will also be necessary to facilitate identification of additional distinct clinico-pathological characteristics or other genotype-phenotype correlations that may have prognostic and management implications.
引用
收藏
页码:116 / 126
页数:11
相关论文
共 88 条
  • [81] A Distinct Subset of Atypical Spitz Tumors is Characterized by BRAF Mutation and Loss of BAP1 Expression
    Wiesner, Thomas
    Murali, Rajmohan
    Fried, Isabella
    Cerroni, Lorenzo
    Busam, Klaus
    Kutzner, Heinz
    Bastian, Boris C.
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2012, 36 (06) : 818 - 830
  • [82] Germline mutations in BAP1 predispose to melanocytic tumors
    Wiesner, Thomas
    Obenauf, Anna C.
    Murali, Rajmohan
    Fried, Isabella
    Griewank, Klaus G.
    Ulz, Peter
    Windpassinger, Christian
    Wackernagel, Werner
    Loy, Shea
    Wolf, Ingrid
    Viale, Agnes
    Lash, Alex E.
    Pirun, Mono
    Socci, Nicholas D.
    Ruetten, Arno
    Palmedo, Gabriele
    Abramson, David
    Offit, Kenneth
    Ott, Arthur
    Becker, Juergen C.
    Cerroni, Lorenzo
    Kutzner, Heinz
    Bastian, Boris C.
    Speicher, Michael R.
    [J]. NATURE GENETICS, 2011, 43 (10) : 1018 - U163
  • [83] The genomic landscapes of human breast and colorectal cancers
    Wood, Laura D.
    Parsons, D. Williams
    Jones, Sian
    Lin, Jimmy
    Sjoblom, Tobias
    Leary, Rebecca J.
    Shen, Dong
    Boca, Simina M.
    Barber, Thomas
    Ptak, Janine
    Silliman, Natalie
    Szabo, Steve
    Dezso, Zoltan
    Ustyanksky, Vadim
    Nikolskaya, Tatiana
    Nikolsky, Yuri
    Karchin, Rachel
    Wilson, Paul A.
    Kaminker, Joshua S.
    Zhang, Zemin
    Croshaw, Randal
    Willis, Joseph
    Dawson, Dawn
    Shipitsin, Michail
    Willson, James K. V.
    Sukumar, Saraswati
    Polyak, Kornelia
    Park, Ben Ho
    Pethiyagoda, Charit L.
    Pant, P. V. Krishna
    Ballinger, Dennis G.
    Sparks, Andrew B.
    Hartigan, James
    Smith, Douglas R.
    Suh, Erick
    Papadopoulos, Nickolas
    Buckhaults, Phillip
    Markowitz, Sanford D.
    Parmigiani, Giovanni
    Kinzler, Kenneth W.
    Velculescu, Victor E.
    Vogelstein, Bert
    [J]. SCIENCE, 2007, 318 (5853) : 1108 - 1113
  • [84] Improved outcome following allogeneic stem cell transplantation in chronic myeloid leukemia is associated with higher expression of BMI-1 and immune responses to BMI-1 protein
    Yong, A. S. M.
    Stephens, N.
    Weber, G.
    Li, Y.
    Savani, B. N.
    Eniafe, R.
    Keyvanfar, K.
    Kurlander, R.
    Rezvani, K.
    Barrett, A. J.
    [J]. LEUKEMIA, 2011, 25 (04) : 629 - 637
  • [85] Frequent inactivation of the BAP1 gene in epithelioid-type malignant mesothelioma
    Yoshikawa, Yoshie
    Sato, Ayuko
    Tsujimura, Tohru
    Emi, Mitsuru
    Morinaga, Tomonori
    Fukuoka, Kazuya
    Yamada, Shusai
    Murakami, Aki
    Kondo, Nobuyuki
    Matsumoto, Seiji
    Okumura, Yoshitomo
    Tanaka, Fumihiro
    Hasegawa, Seiki
    Nakano, Takashi
    Hashimoto-Tamaoki, Tomoko
    [J]. CANCER SCIENCE, 2012, 103 (05): : 868 - 874
  • [86] Frequent deletion of 3p21.1 region carrying semaphorin 3G and aberrant expression of the genes participating in semaphorin signaling in the epithelioid type of malignant mesothelioma cells
    Yoshikawa, Yoshie
    Sato, Ayuko
    Tsujimura, Tohru
    Morinaga, Tomonori
    Fukuoka, Kazuya
    Yamada, Shusai
    Murakami, Aki
    Kondo, Nobuyuki
    Matsumoto, Seiji
    Okumura, Yoshitomo
    Tanaka, Fumihiro
    Hasegawa, Seiki
    Hashimoto-Tamaoki, Tomoko
    Nakano, Takashi
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 2011, 39 (06) : 1365 - 1374
  • [87] The Ubiquitin Carboxyl Hydrolase BAP1 Forms a Ternary Complex with YY1 and HCF-1 and Is a Critical Regulator of Gene Expression
    Yu, Helen
    Mashtalir, Nazar
    Daou, Salima
    Hammond-Martel, Ian
    Ross, Julie
    Sui, Guangchao
    Hart, Gerald W.
    Rauscher, Frank J., III
    Drobetsky, Elliot
    Milot, Eric
    Shi, Yang
    Affar, El Bachir
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2010, 30 (21) : 5071 - 5085
  • [88] A histone H2A deubiquitinase complex coordinating histone acetylation and H1 dissociation in transcriptional regulation
    Zhu, Ping
    Zhou, Wenlai
    Wang, Jianxun
    Puc, Janusz
    Ohgi, Kenneth A.
    Erdjument-Bromage, Hediye
    Tempst, Paul
    Glass, Christopher K.
    Rosenfeld, Michael G.
    [J]. MOLECULAR CELL, 2007, 27 (04) : 609 - 621